Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dopamine | 11 | 2014 | 275 | 1.850 |
Why?
|
| S-Adenosylmethionine | 11 | 2008 | 41 | 1.300 |
Why?
|
| Levodopa | 6 | 2014 | 26 | 1.260 |
Why?
|
| Parkinson Disease | 6 | 2012 | 210 | 1.090 |
Why?
|
| Antiparkinson Agents | 3 | 2014 | 14 | 1.050 |
Why?
|
| Corpus Striatum | 6 | 2014 | 121 | 0.890 |
Why?
|
| Parkinsonian Disorders | 3 | 2014 | 42 | 0.880 |
Why?
|
| Tyrosine 3-Monooxygenase | 7 | 2012 | 92 | 0.770 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 5 | 2014 | 15 | 0.680 |
Why?
|
| Methanol | 2 | 2012 | 22 | 0.670 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2014 | 18 | 0.520 |
Why?
|
| Behavior, Animal | 5 | 2012 | 373 | 0.500 |
Why?
|
| Lysophosphatidylcholines | 3 | 2005 | 22 | 0.500 |
Why?
|
| Tyrosine | 2 | 2007 | 120 | 0.480 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 2 | 2012 | 5 | 0.450 |
Why?
|
| Methylation | 8 | 2014 | 119 | 0.430 |
Why?
|
| Motor Activity | 5 | 2010 | 437 | 0.400 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2012 | 192 | 0.400 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 1596 | 0.350 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2008 | 1766 | 0.350 |
Why?
|
| Rats | 15 | 2008 | 3735 | 0.350 |
Why?
|
| Dopamine Antagonists | 3 | 2007 | 48 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 6 | 2014 | 1869 | 0.330 |
Why?
|
| Brain Chemistry | 5 | 2007 | 141 | 0.330 |
Why?
|
| Animals | 21 | 2014 | 16992 | 0.310 |
Why?
|
| MPTP Poisoning | 2 | 2006 | 12 | 0.300 |
Why?
|
| Formates | 1 | 2008 | 6 | 0.290 |
Why?
|
| Formaldehyde | 1 | 2008 | 31 | 0.290 |
Why?
|
| Brain | 3 | 2004 | 1472 | 0.280 |
Why?
|
| Paraquat | 1 | 2006 | 20 | 0.240 |
Why?
|
| Neurotoxins | 1 | 2006 | 57 | 0.230 |
Why?
|
| Homocysteine | 1 | 2005 | 21 | 0.230 |
Why?
|
| Mice | 7 | 2014 | 6644 | 0.230 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2005 | 38 | 0.220 |
Why?
|
| Methionine | 2 | 2002 | 27 | 0.210 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2003 | 8 | 0.210 |
Why?
|
| Receptors, Dopamine | 1 | 2004 | 30 | 0.210 |
Why?
|
| Cystine | 1 | 2003 | 14 | 0.210 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 100 | 0.200 |
Why?
|
| Male | 16 | 2014 | 23409 | 0.200 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 224 | 0.190 |
Why?
|
| Substantia Nigra | 3 | 2005 | 52 | 0.190 |
Why?
|
| Parkinson Disease, Secondary | 2 | 2011 | 12 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 386 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2007 | 465 | 0.170 |
Why?
|
| Methionine Adenosyltransferase | 2 | 2004 | 3 | 0.160 |
Why?
|
| Cell Differentiation | 1 | 2002 | 638 | 0.150 |
Why?
|
| Homovanillic Acid | 2 | 2010 | 10 | 0.140 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 2 | 2010 | 27 | 0.140 |
Why?
|
| Injections, Intraventricular | 3 | 2005 | 59 | 0.130 |
Why?
|
| PC12 Cells | 3 | 2007 | 93 | 0.130 |
Why?
|
| Nerve Degeneration | 2 | 1994 | 111 | 0.130 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2007 | 59 | 0.120 |
Why?
|
| Pregnancy | 2 | 2012 | 1772 | 0.120 |
Why?
|
| Benzazepines | 2 | 2007 | 33 | 0.120 |
Why?
|
| Receptors, Dopamine D1 | 2 | 2007 | 46 | 0.120 |
Why?
|
| Phosphatidylethanolamine N-Methyltransferase | 2 | 2005 | 6 | 0.110 |
Why?
|
| Neurons | 1 | 2002 | 1263 | 0.110 |
Why?
|
| Cell Survival | 2 | 2008 | 945 | 0.110 |
Why?
|
| Apoptosis | 1 | 2002 | 1568 | 0.110 |
Why?
|
| Drug Synergism | 2 | 2006 | 195 | 0.110 |
Why?
|
| Phospholipids | 2 | 2005 | 70 | 0.110 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 2 | 2005 | 28 | 0.110 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 153 | 0.100 |
Why?
|
| Movement Disorders | 1 | 1993 | 9 | 0.100 |
Why?
|
| Kinetics | 2 | 2005 | 695 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 457 | 0.100 |
Why?
|
| alpha-Synuclein | 1 | 2012 | 61 | 0.090 |
Why?
|
| Catecholamines | 2 | 2007 | 45 | 0.090 |
Why?
|
| Birth Weight | 1 | 2010 | 95 | 0.080 |
Why?
|
| Time Factors | 1 | 2014 | 1857 | 0.080 |
Why?
|
| Respiratory Muscles | 1 | 1988 | 10 | 0.070 |
Why?
|
| Muscles | 1 | 1988 | 82 | 0.070 |
Why?
|
| Respiration | 1 | 1988 | 56 | 0.070 |
Why?
|
| Motor Neurons | 1 | 1988 | 90 | 0.070 |
Why?
|
| Mitochondrial Membranes | 1 | 2007 | 41 | 0.070 |
Why?
|
| Membrane Potentials | 1 | 2007 | 222 | 0.060 |
Why?
|
| Female | 3 | 2012 | 24698 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 149 | 0.060 |
Why?
|
| S-Adenosylhomocysteine | 2 | 2005 | 11 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2008 | 883 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1070 | 0.060 |
Why?
|
| Herbicides | 1 | 2006 | 43 | 0.060 |
Why?
|
| Catheterization | 1 | 2005 | 22 | 0.060 |
Why?
|
| Neostriatum | 1 | 2005 | 28 | 0.060 |
Why?
|
| Quinacrine | 1 | 2005 | 5 | 0.060 |
Why?
|
| Hypokinesia | 1 | 2005 | 4 | 0.060 |
Why?
|
| Adenosine | 1 | 2005 | 62 | 0.060 |
Why?
|
| Chromatography, Thin Layer | 1 | 2005 | 39 | 0.060 |
Why?
|
| Pyridinium Compounds | 1 | 2005 | 29 | 0.060 |
Why?
|
| Pineal Gland | 1 | 2004 | 31 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 783 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 532 | 0.050 |
Why?
|
| Mazindol | 1 | 2004 | 4 | 0.050 |
Why?
|
| Tritium | 1 | 2004 | 46 | 0.050 |
Why?
|
| Serotonin | 1 | 2005 | 123 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2004 | 65 | 0.050 |
Why?
|
| Methyltransferases | 1 | 2005 | 68 | 0.050 |
Why?
|
| Dizocilpine Maleate | 1 | 2004 | 43 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2004 | 109 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2004 | 127 | 0.050 |
Why?
|
| Protein Methyltransferases | 1 | 2003 | 6 | 0.050 |
Why?
|
| Hyperkinesis | 1 | 2003 | 7 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2004 | 92 | 0.050 |
Why?
|
| Amphetamine | 1 | 2003 | 21 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 166 | 0.050 |
Why?
|
| Body Temperature | 1 | 2003 | 35 | 0.050 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2004 | 83 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2004 | 240 | 0.050 |
Why?
|
| Benzamides | 1 | 2004 | 81 | 0.050 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2004 | 83 | 0.050 |
Why?
|
| Tremor | 2 | 1993 | 9 | 0.050 |
Why?
|
| Triazoles | 1 | 2003 | 102 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 934 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 26 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 49 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 575 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 76 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2002 | 64 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 98 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2002 | 79 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 506 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2004 | 403 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2003 | 180 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 152 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 458 | 0.040 |
Why?
|
| Liver | 1 | 2005 | 511 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 2676 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1124 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 257 | 0.040 |
Why?
|
| Protein Binding | 1 | 2004 | 1082 | 0.040 |
Why?
|
| Proteins | 1 | 2002 | 382 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2004 | 141 | 0.030 |
Why?
|
| Immobilization | 1 | 1993 | 11 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1992 | 47 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1993 | 150 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1992 | 25 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1993 | 206 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 1992 | 159 | 0.020 |
Why?
|
| Inhalation | 1 | 1988 | 8 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 126 | 0.020 |
Why?
|
| Phosphatidylethanolamines | 1 | 2005 | 17 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 2005 | 35 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2004 | 236 | 0.010 |
Why?
|
| Humans | 1 | 2006 | 43102 | 0.010 |
Why?
|